4//SEC Filing
Gruskin Daniel 4
Accession 0001209191-21-050681
CIK 0001664106other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:31 PM ET
Size
8.9 KB
Accession
0001209191-21-050681
Insider Transaction Report
Form 4
Gruskin Daniel
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-06+4,798→ 4,798 total - Sale
Common Stock
2021-08-09$4.35/sh−1,467$6,381→ 3,331 total - Exercise/Conversion
Restricted Stock Units
2021-08-06−4,798→ 0 total→ Common Stock (4,798 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
- [F2]This sale was made automatically by the Company to cover tax withholding obligations in connection with the vesting and settlement of the RSUs reported in the row above.
- [F3]These RSUs vested on August 6, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001863053
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 6:31 PM ET
- Size
- 8.9 KB